Skip to main content

Drug Interactions between allogeneic processed thymus tissue and sars-cov-2 mrna (tozinameran) vaccine

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Major

SARS-CoV-2 mRNA (tozinameran) vaccine allogeneic processed thymus tissue

Applies to: sars-cov-2 mrna (tozinameran) vaccine and allogeneic processed thymus tissue

Patients that have been treated with allogeneic processed thymus tissue should let their doctor know before receiving SARS-CoV-2 mRNA (tozinameran) vaccine. Allogeneic processed thymus tissue is intended to help the body develop a part of the immune system called T cells, which are important to help the body fight infections and can help vaccines work to protect the body against certain diseases. Depending on the length of time since they have been treated with allogeneic processed thymus tissue, their body may not have had enough time to develop this part of the immune system, which may lead to a reduced response to SARS-CoV-2 mRNA (tozinameran) vaccine. In some situations, their doctor may want to delay vaccination with SARS-CoV-2 mRNA (tozinameran) vaccine until the patient's immune system is improved. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer